Study of health-related quality of life in patients with chronic hepatitis C treated with sofosbuvir-based treatment at 1-year post-sustained virological response
Latest Information Update: 15 Dec 2021
At a glance
- Drugs Ledipasvir/sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 15 Dec 2021 New trial record
- 01 Dec 2021 Results published in the Quality of Life Research